{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T19:35:18Z","timestamp":1783625718364,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.leukres.2018.05.009","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T19:31:38Z","timestamp":1529350298000},"page":"6-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Cytoplasmic CD3 expression in infant acute megakaryoblastic leukemia: A new ambiguous lineage subtype?"],"prefix":"10.1016","volume":"71","author":[{"given":"Jorge Gabriel","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina N.","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea R.","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa O.","family":"Sajaroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Digiorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgardo","family":"Baialardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Eandi-Eberle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Guitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Fernandez-Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sara","family":"Felice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2018.05.009_bib0005","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukaemias: European Group for the Immunological Characterization of Leukaemias (EGIL)","volume":"9","author":"Bene","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2018.05.009_bib0010","series-title":"WHO Classification Pathology and Genetics of Tumours of the Haemopoietic and Lymphoid Tissues","first-page":"106","author":"Brunning","year":"2001"},{"key":"10.1016\/j.leukres.2018.05.009_bib0015","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"150","author":"Borowitz","year":"2008"},{"issue":"20","key":"10.1016\/j.leukres.2018.05.009_bib0020","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2018.05.009_bib0025","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"180","author":"Borowitz","year":"2017"},{"key":"10.1016\/j.leukres.2018.05.009_bib0030","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/ni.2255","article-title":"The earliest thymic T. cell progenitors sustain B. cell and myeloid lineage potentials","volume":"13","author":"Luc","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.leukres.2018.05.009_bib0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cell.2006.06.037","article-title":"New evidence supporting megakaryocyte-erythrocyte potential of flk2\/flt3+ multipotent hematopoietic progenitors","volume":"126","author":"Forsberg","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2018.05.009_bib0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.it.2009.03.001","article-title":"A new paradigm for hematopoietic cell lineages: revision of the classical concept of the myeloid-lymphoid dichotomy","volume":"30","author":"Kawamoto","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.leukres.2018.05.009_bib0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-065X.2010.00959.x","article-title":"A map for lineage restriction of progenitors during hematopoiesis: the essence of the myeloid-based model","volume":"23","author":"Kawamoto","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.leukres.2018.05.009_bib0050","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1182\/blood-2015-07-607945","article-title":"Hematopoietic stem\/progenitor cell commitment to the megakaryocyte lineage","volume":"127","author":"Woolthuis","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2018.05.009_bib0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/cyto.b.21518","article-title":"International-BFM-FLOW-network. AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia","volume":"94","author":"Dworzak","year":"2018","journal-title":"Cytometry B Clin. Cytom."},{"key":"10.1016\/j.leukres.2018.05.009_bib0060","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/cyto.b.21082","article-title":"DworzakM. Blast cell deficiency of CD11a asa marker of acute megakaryoblastic leukaemia and transientmyeloproliferative disease in children with and without Down syndrome","volume":"84","author":"Boztug","year":"2013","journal-title":"Cytometry B Clin. Cytom."},{"key":"10.1016\/j.leukres.2018.05.009_bib0065","series-title":"WHO Classification of Tumors of the Haemopoietic and Lymphoid Tissues","first-page":"156","author":"Arber","year":"2017"},{"key":"10.1016\/j.leukres.2018.05.009_bib0070","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/cytob.21198","article-title":"Acute megakaryoblastic leukaemia associated with trisomy 21 demonstrates a distinct immunophenotype","volume":"88","author":"Wang","year":"2015","journal-title":"Cytometry B Clin. Cytom."},{"key":"10.1016\/j.leukres.2018.05.009_bib0075","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1200\/JCO.2010.28.3390","article-title":"Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia","volume":"28","author":"Gutierrez","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2018.05.009_bib0080","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3324\/haematol.2013.090233","article-title":"Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors","volume":"99","author":"Zuurbier","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2018.05.009_bib0085","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/sj.leu.2404578","article-title":"Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement","volume":"21","author":"Jansen","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2018.05.009_bib0090","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukemia: a subtype of very high-risk acute lymphoblastic leukemia identified in two independant cohorts","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.leukres.2018.05.009_bib0095","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3324\/haematol.2009.014506","article-title":"Prognosis of children with mixed phenotype acute leukaemia treated on the basis of consistent immunophenotypic criteria","volume":"95","author":"Mejstrikova","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2018.05.009_bib0100","first-page":"699","article-title":"Outcome of biphenotypic acute leukaemia","volume":"84","author":"Killick","year":"1999","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2018.05.009_bib0105","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1182\/blood-2008-10-187351","article-title":"Acute mixed lineage leukaemia in children: the experience of St Jude Children's Research Hospital","volume":"113","author":"Rubnitz","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2018.05.009_bib0110","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1365-2141.2009.08058.x","article-title":"Acute leukaemias of ambiguous lineage in children: characterization, prognosis and therapy recommendations","volume":"149","author":"Gerr","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2018.05.009_bib0115","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1182\/blood-2010-10-314682","article-title":"Mixed-phenotype acute leukaemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification","volume":"117","author":"Matutes","year":"2011","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212618301115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212618301115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T17:25:53Z","timestamp":1533230753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212618301115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":23,"alternative-id":["S0145212618301115"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2018.05.009","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytoplasmic CD3 expression in infant acute megakaryoblastic leukemia: A new ambiguous lineage subtype?","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2018.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}